Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Sep 6;12(9):e231093.
doi: 10.1136/bcr-2019-231093.

Partial nephrogenic diabetes insipidus associated with lithium therapy

Affiliations
Case Reports

Partial nephrogenic diabetes insipidus associated with lithium therapy

Eka Nandoshvili et al. BMJ Case Rep. .

Corrected and republished in

Abstract

A 40-year-old Caucasian man developed excessive thirst and polyuria particularly at night over the preceding 6 months. He had been taking lithium for 16 years for the treatment of bipolar affective disorder. Investigations revealed subnormal maximum urinary concentrating ability after 8 hours of water deprivation and only a borderline response of urine osmolality to exogenous desmopressin given by intramuscular injection. A plasma copeptin concentration was elevated at 23 pmol/L. These results were consistent with partial nephrogenic diabetes insipidus. He was encouraged to increase his water intake as dictated by his thirst. In addition, he received amiloride with some improvement in his symptoms. Clinicians should be aware of the risk of nephrogenic diabetes insipidus with long-term lithium use and seek confirmation by a supervised water deprivation test augmented with a baseline plasma copeptin. If increased water intake is insufficient to control symptoms, amiloride may be considered.

Keywords: drugs: endocrine system; fluid electrolyte and acid-base disturbances.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

Cited by

References

    1. Timper K, Fenske W, Kühn F, et al. . Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study. J Clin Endocrinol Metab 2015;100:2268–74. 10.1210/jc.2014-4507 - DOI - PubMed
    1. Fenske W, Quinkler M, Lorenz D, et al. . Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests. J Clin Endocrinol Metab 2011;96:1506–15. 10.1210/jc.2010-2345 - DOI - PubMed
    1. Grünfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol 2009;5:270–6. 10.1038/nrneph.2009.43 - DOI - PubMed
    1. Bedford JJ, Weggery S, Ellis G, et al. . Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. Clin J Am Soc Nephrol 2008;3:1324–31. 10.2215/CJN.01640408 - DOI - PMC - PubMed
    1. Kortenoeven MLA, Schweer H, Cox R, et al. . Lithium reduces aquaporin-2 transcription independent of prostaglandins. Am J Physiol Cell Physiol 2012;302:C131–C140. 10.1152/ajpcell.00197.2011 - DOI - PubMed

Publication types

MeSH terms